Darba® 40 Injection Darba 40 Injection contains darbepoetin alfa, a long-acting erythropoiesis-stimulating agent used to treat anemia associated with chronic kidney disease (CKD) and anemia caused by chemotherapy in certain cancer patients. It works by stimulating the bone marrow to produce more red blood cells, helping increase hemoglobin levels and improving oxygen delivery throughout the body.

Effects & Benefits Helps increase red blood cell production. Treats anemia associated with chronic kidney disease (CKD). Used to manage chemotherapy-induced anemia in eligible cancer patients. Improves hemoglobin levels and oxygen transport. Helps reduce fatigue, weakness, and shortness of breath caused by anemia. Long-acting formulation allows less frequent dosing. Possible Side Effects

Like all medicines, Darba 40 Injection may cause side effects, although not everyone experiences them.